Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 6, 2013Im Rahmen der TCT-Konferenz präsentierte Daten der REDUCE-HTN Studie belegen das exzellente Sicherheitsprofil
Bei Patienten, die mit dem Vessix™-System zur renalen Denervierung von Boston Scientific (NYSE: BSX) behandelt wurden, zeigte sich eine signifikante und nachhaltige Blutdrucksenkung. Dies...
-
Nov 1, 2013
Boston Scientific Corporation (NYSE:BSX) today closed on its previously announced agreement to acquire Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. The completion of this...
-
Oct 30, 2013
Boston Scientific Corporation (NYSE:BSX) today announced the first German patient enrolment in the EWOLUTION REgistry on WATCHMAN Outcomes in Real-Life Utilization, a prospective multicentre...
-
Oct 30, 2013
Boston Scientific Corporation (NYSE:BSX) ha anunciado hoy la primera inscripción en el registro EWOLUTION con la utilización del dispositivo WATCHMAN en la vida real. Se trata de un registro...
-
Oct 28, 2013REDUCE-HTN Data Presented Today at TCT Demonstrate Excellent Safety Profile
Patients treated with the Boston Scientific (NYSE: BSX) Vessix™ Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented...